Pharma IQ Members

Market Access

Find out everything you need to know about the latest pricing, reimbursement and market access strategies that will drive your business development.

231 results
of 21
Contributor: Chanice Henry
Posted: Tue, 01/16/2018
pills thumb
The market share of generics in Portugal reached a new record recently, according to provisional figures from Infarmed. Full Content »
Contributor: Chanice Henry
Posted: Fri, 01/05/2018
Money pharmaceutical
A new national price list for medical services went live on the first of January Full Content »
Contributor: Pharma IQ
Posted: Wed, 01/03/2018
Calendars thumb
Download this calendar to view the editorial focus for Pharma and Pharma Logistics IQ for 2018. Full Content »
Contributor: Catalyst Corporate Finance
Posted: Tue, 12/05/2017
Despite concern expressed by the pharmaceutical industry, Catalyst Corporate Finance argues that the UK’s decision to leave the European Union in fact represents a major opportunity for the country’s dynamic and world-leading pharmaceutical sector. Full Content »
Contributor: David B. Sudzus
Posted: Tue, 12/05/2017
David B. Sudzus
David B. Sudzus and Russell J. Chibe explore possible outcomes of the Blue Ribbon Commission Report and the Declaration of National Health Emergency regarding the U.S’s Opioid Crisis. Full Content »
Contributor: Joyce El Hokayem
Posted: Tue, 11/21/2017
lab plant
Human Genetics Scientist, Joyce El Hokayem examines the benefits phytomedicine could offer to today’s healthcare systems and the challenges researchers in this market face Full Content »
Contributor: Pharma IQ News
Posted: Tue, 10/31/2017
Pharma IQ looks at the potential of artificial intelligence in drug discovery. Full Content »
Contributor: Katie Sadler
Posted: Tue, 10/31/2017
Katie Sadler
Indian pharmaceutical production expected grow 15 per cent by 2020 with domestic buying power sustaining revenues Full Content »
Contributor: Regina Au
Posted: Mon, 10/30/2017
Social minds
While social media is taking the consumer world by storm, the medical industry has been a bit shy to fully embrace these channels because of regulatory requirements. Full Content »
Contributor: Dr Steven Bradshaw
Posted: Tue, 09/26/2017
Dr Steven Bradshaw
Pharma treads a fine line to the tipping point where there is insufficient time to recoup a drug’s costs, due to the number of years left that the patent can run. Full Content »
Contributor: Chanice Henry
Posted: Tue, 09/19/2017
As the globe’s health systems groan under financial pressure, analysts have identified large differences in the amounts European patients pay for generics. Full Content »
231 results
of 21